For in vitro and preclinical investigation
At En Vogue IV Therapy & Wellness Clinic, we use both liraglutide (Saxenda) and Semaglutide GLP-1 (Wegovy), which are injectable glucagon-like peptide-1 (GLP-1) receptor agonists, to assist patients in weight loss
One of the most helpful ways to look at the data is by dose
In July 2024, Roche, a Swiss-based pharmaceuticals company, acquired Carmot Therapeutics for US$ 2.7 billion (with up to US$ 400 million in additional milestone payments)
The drug performed better on all secondary endpoints as well, including a greater percentage of people losing at least 15% of their weight (roughly a third of those on the highest dose achieved this)
Our kosher and Non-GMO certified formula is manufactured in the USA by a trusted family-owned company